Needham analyst Michael Matson reiterated a Buy rating on NeoGenomics (NEO – Research Report) today and set a price target of $19.00.Stay Ahead ...

NeoGenomics (NASDAQ:NEO) shares popped ~4% premarket on Wednesday after the oncology testing services company set a revenue ...

The company said, “The Long-Range Plan builds upon the successful execution of the previous three years. NeoGenomics (NEO) intends to achieve ...

NeoGenomics (NEO) shares ended the last trading session 9.1% higher at $13.78. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...

NeoGenomics is providing financial guidance 1 for 2025. The Company expects total revenues in the range of $735 million to $745 million and adjusted EBITDA in the range of $55 million to $58 million.

The Magnus Neo represents the evolution of Ampere's Magnus EX and is set to deliver more style, more power, more strength, more safety, and more savings. The Magnus Neo will take center stage at Auto ...

The Middle East is undergoing a profound transformation as new rivalries reshape its geopolitical order. For decades, the ...

Known for her commitment to championing Southeast Asian contemporary art, Singaporean art collector Linda Neo, together with ...

NeoGenomics (NASDAQ:NEO – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at Needham & Company LLC in a note issued to investors on Friday,Benzinga reports. They ...

MoneyShow presents top investment ideas for 2024 from leading advisors. Part 2 includes Neo Performance Metals, Fannie Mae, ...

Neo Asset Management, founded in 2021 and backed by venture company Peak XV Partners as well as Japanese financial group MUFG ...

As neo-banks continue to evolve and innovate, they are not just disrupting the traditional banking sector—they are setting a ...